Last reviewed · How we verify

NCT02911103

Deep Brain Stimulation Surgery for Focal Hand Dystonia

Active, enrolled Phase 1, PHASE2 Last updated 27 March 2026
What this trial tests

Phase 1, PHASE2 trial testing DBS surgery in Dystonia in 5 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
17 January 2018
Primary endpoint
2 February 2029
2 February 2029

Quick facts

Lead sponsorNational Institute of Neurological Disorders and Stroke (NINDS)
PhasePhase 1, PHASE2
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment5
Start date17 January 2018
Primary completion2 February 2029
Estimated completion2 February 2029
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)

Who can join

Adults 22 to 100, any sex, with Dystonia or Focal Dystonia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Researchers want to test a procedure called deep brain simulation (DBS) to treat focal hand dystonia (FHD). A device called a neurostimulator is placed in the chest. It is attached to wires placed in brain areas that affect movement. Stimulating these areas can help block nerve signals that cause abnormal movements. Objectives: To test DBS as treatment for FHD. To learn about brain and nerve cell function in people with dystonia. Eligibility: People ages 18 and older with severe FHD who have tried botulinum toxin treatment at least twice Design: Participation lasts 5 years. Participants will be screened with: Medical history Physical exam Videotape of their dystonia Blood, urine, and heart tests Brain MRI scan Chest X-ray Neuropsychological tests: answering questions, doing simple actions, and taking memory and thinking tests. Hand movement tests Participants will have surgery: A frame fixes their head to the operating table. A small hole is made in the skull. Wires are inserted to record brain activity and stimulate the brain while they do simple tasks. The wires are removed and the DBS electrode is inserted into the hole. The neurostimulator is placed under the skin of the chest, with wires running to the electrode in the brain. They will have CT and MRI scans during surgery. Participants will recover in the hospital for about 1 week. The neurostimulator will be turned on 1 4 weeks after discharge. Participants will have regular visits until the study ends. Visits include: Checking symptoms and side effects MRI Movement, thinking, and memory tests If the neurostimulator s battery runs out, participants will have surgery to replace it.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation.
    Bledsoe IO, Viser AC, San Luciano M. · · 2020 · cited 34× · PMID 33095402 · DOI 10.1007/s13311-020-00944-0
  2. Deep Brain Stimulation for the Management of Refractory Neurological Disorders: A Comprehensive Review.
    Rissardo JP, Vora NM, Tariq I, Mujtaba A, et al · · 2023 · cited 17× · PMID 38004040 · DOI 10.3390/medicina59111991

Verify or expand the search:

Other recruiting trials for Dystonia

Currently open trials in the same condition.

Other National Institute of Neurological Disorders and Stroke (NINDS) trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02911103.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing